Literature DB >> 11550278

Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma.

K Yasui1, I Imoto, Y Fukuda, A Pimkhaokham, Z Q Yang, T Naruto, Y Shimada, Y Nakamura, J Inazawa.   

Abstract

Comparative genomic hybridization studies have revealed frequent amplification of the 14q12-q13 region in esophageal squamous cell carcinoma (ESC) cell lines. To identify genes targeted for amplification, we first defined the minimal common region of amplification using fluorescence in situ hybridization in affected ESC cell lines. The amplicon covered about 6 Mb, between markers D14S1034 and L18528. Then we screened 32 ESC cell lines to discern amplifications and expression levels of 26 expressed sequence tags (ESTs) that had been localized to the amplified region. Five known genes (BAZ1A, SRP54, NFKBIA, MBIP, and HNF3A) and two uncharacterized ESTs (GenBank Accession numbers AA991861 and AA167732) within the amplicon showed amplification and consequent overexpression. Two of these transcripts were amplified in three of the primary ESCs we examined. Our findings suggest that these seven genes are candidate targets of the amplification mechanism and therefore may be associated, together or separately, with development and progression of ESC. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11550278     DOI: 10.1002/gcc.1172

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers.

Authors:  Sana Yokoi; Kohichiroh Yasui; Fumiko Saito-Ohara; Katsumi Koshikawa; Toshihiko Iizasa; Takehiko Fujisawa; Takeo Terasaki; Akira Horii; Takashi Takahashi; Setsuo Hirohashi; Johji Inazawa
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

2.  Reduced levels of ATF-2 predispose mice to mammary tumors.

Authors:  Toshio Maekawa; Toshie Shinagawa; Yuji Sano; Takahiko Sakuma; Shintaro Nomura; Koichi Nagasaki; Yoshio Miki; Fumiko Saito-Ohara; Johji Inazawa; Takashi Kohno; Jun Yokota; Shunsuke Ishii
Journal:  Mol Cell Biol       Date:  2006-12-22       Impact factor: 4.272

3.  Defective anchoring of JNK1 in the cytoplasm by MKK7 in Jurkat cells is associated with resistance to Fas-mediated apoptosis.

Authors:  Jing Wang; Ruihong Tang; Ming Lv; Qingyang Wang; Xueying Zhang; Yuanyuan Guo; Hong Chang; Chunxia Qiao; He Xiao; Xinying Li; Yan Li; Beifen Shen; Jiyan Zhang
Journal:  Mol Biol Cell       Date:  2010-12-09       Impact factor: 4.138

Review 4.  Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes.

Authors:  Nair Lopes; Margareta P Correia; Rui Henrique; Carmen Jerónimo
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 5.  The emerging role of ISWI chromatin remodeling complexes in cancer.

Authors:  Yanan Li; Han Gong; Pan Wang; Yu Zhu; Hongling Peng; Yajuan Cui; Heng Li; Jing Liu; Zi Wang
Journal:  J Exp Clin Cancer Res       Date:  2021-11-04

6.  FOXA1 mutations in hormone-dependent cancers.

Authors:  Jessica L L Robinson; Kelly A Holmes; Jason S Carroll
Journal:  Front Oncol       Date:  2013-02-14       Impact factor: 6.244

7.  Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas.

Authors:  R F Rodrigues; L Roque; J Rosa-Santos; O Cid; J Soares
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

8.  Association of common polymorphisms in TNFA, NFkB1 and NFKBIA with risk and prognosis of esophageal squamous cell carcinoma.

Authors:  Meenakshi Umar; Rohit Upadhyay; Shaleen Kumar; Uday Chand Ghoshal; Balraj Mittal
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

9.  CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways.

Authors:  Giulia Gallerani; Tania Rossi; Martina Valgiusti; Davide Angeli; Pietro Fici; Sara De Fanti; Erika Bandini; Claudia Cocchi; Giovanni Luca Frassineti; Massimiliano Bonafè; Francesco Fabbri
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.